Net profit of Supriya Lifescience rose 9.27% to Rs 50.43 crore in the quarter ended September 2025 as against Rs 46.15 crore during the previous quarter ended September 2024. Sales rose 20.31% to Rs 199.83 crore in the quarter ended September 2025 as against Rs 166.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales199.83166.10 20 OPM %36.3638.96 - PBDT74.9666.81 12 PBT68.3262.07 10 NP50.4346.15 9 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live News

Supriya Lifesciences announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2025.Powered by Capital Market - Live News

Net profit of Supriya Lifescience declined 22.07% to Rs 34.79 crore in the quarter ended June 2025 as against Rs 44.64 crore during the previous quarter ended June 2024. Sales declined 9.69% to Rs 145.07 crore in the quarter ended June 2025 as against Rs 160.63 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales145.07160.63 -10 OPM %35.6438.94 - PBDT53.8764.43 -16 PBT47.4259.77 -21 NP34.7944.64 -22 Powered by Capital Market - Live News

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News